United States Phospholipids Market 2026 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth 2026

Global Phospholipids Market reached US$ 2.97 billion in 2023 and is expected to reach US$ 5.13 billion by 2031, growing with a CAGR of 7.03% during the forecast period 2024-2031.

Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/phospholipids-market?sb

DataM Intelligence has released a new research report titled Phospholipids Market Size 2026 The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Phospholipids market.

Key Developments 2025-2026:

United States: Recent Industry Developments

✅ In March 2026, Croda International expanded its U.S. phospholipid manufacturing capacity through its Avanti Polar Lipids operations to support growing demand in lipid-based drug delivery systems. The expansion focuses on high-purity phospholipids for mRNA and liposomal formulations. It strengthens supply chain resilience for advanced therapeutics.

✅ In February 2026, Thermo Fisher Scientific enhanced its lipid and phospholipid reagent production capabilities to support cell therapy and nanoparticle-based drug development. The initiative targets improved scalability for pharmaceutical and biotech customers. It reinforces Thermo Fisher's role in advanced drug formulation materials.

✅ In January 2026, CordenPharma announced capacity expansion for pharmaceutical-grade phospholipid production used in injectable and lipid nanoparticle drug delivery systems. The development supports rising demand in biologics and RNA-based therapies. It strengthens its position in specialty excipient manufacturing.

✅ In January 2026, Danaher Corporation through its Precision NanoSystems division advanced new phospholipid-based formulation platforms for gene therapy and nucleic acid delivery. The focus is on improving lipid nanoparticle stability and efficiency. It enhances innovation in next-generation drug delivery systems.

Ready to scale in the Phospholipids Market? Connect with the right partners and unlock new growth opportunities today:- https://www.datamintelligence.com/partner-identification-enquiry/phospholipids-market?sb

Japan: Recent Industry Developments

✅ In March 2026, NOF Corporation expanded its phospholipid production capabilities to support pharmaceutical applications including liposomes and drug delivery systems. The development focuses on high-purity excipients for advanced therapeutics. It strengthens Japan's position in pharmaceutical lipid manufacturing.

✅ In February 2026, Nippon Fine Chemical Co. Ltd advanced new phospholipid formulation technologies targeting injectable drug delivery systems and cosmetic applications. The initiative emphasizes improved stability and bioavailability. It enhances its specialty chemical portfolio in life sciences.

✅ In January 2026, Nisshin OilliO Group expanded its lecithin and phospholipid processing operations to meet rising demand from pharmaceutical and nutraceutical industries. The expansion supports high-quality lipid ingredient supply chains. It strengthens Japan's functional lipid production ecosystem.

✅ In January 2026, Mitsubishi Chemical Group enhanced its lipid-based material research focusing on phospholipid applications in drug delivery and biomedical engineering. The development supports innovation in advanced healthcare materials. It reinforces Japan's leadership in biochemical material science.

List of Key Players 2026:

=> Cargill, Inc., Archer Daniels Midland Company, Bunge Ltd, Lipoid GmbH, VAV Life Sciences, American Lecithin Company, Kewpie Corporation, Lecico GmbH, Nabros Pharma Pvt. Ltd., and Croda International Plc.

Request Strategic Market Customization: https://datamintelligence.com/customize/phospholipids-market?sb

Growth Forecast Projection 2026:

The Global Phospholipids Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

How Our Market Research Process Works:

The global Phospholipids Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Phospholipids ecosystem.

Recent Mergers & Acquisitions (M & A) 2025-2026:

✅ In April 2026, BASF expanded its life sciences and nutrition portfolio through strategic integration of lipid and emulsifier assets, strengthening its position in phospholipid-based ingredients for pharma and food applications.

✅ In March 2026, Cargill continued portfolio consolidation in its specialty ingredients segment, focusing on lecithin and phospholipid derivatives used in nutraceuticals, infant nutrition, and drug delivery systems.

✅ In February 2026, ADM advanced its specialty ingredients expansion strategy by strengthening its lecithin and phospholipid production capabilities, supporting demand from pharmaceuticals and functional food industries.

Unlock Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=phospholipids-market?sb

Major Focused Key Segmentations 2026:

➥ By Type: Phosphatidylserine, Phosphatidylcholine, Others

➥ By Source: Soy, Sunflower, Egg, Others

➥ By Functionality: Emulsifying, Wetting & Dispersion, Thickening & Gelling, Nutrient Delivery

➥ By Application: Food & Beverage, Nutraceutical Supplements, Pharmaceuticals, Others

➥ By Region: North America, South America, Europe, Asia Pacific, Middle East & Africa - Share, Size, Outlook, and Opportunity Analysis (2026-2033)

Regional Growth Analysis for Market:

⇥ North America: Leads the Phospholipids market with strong R&D investments, advanced material innovation, and growing adoption across electronics, energy storage, and aerospace sectors.

⇥ Asia-Pacific (including Japan): Dominates global demand, driven by large-scale production, expanding applications in electronics, batteries, and industrial manufacturing across China, Japan, and India.

⇥ Europe: Significant growth supported by government-funded research initiatives, sustainability focus, and increasing use in automotive and renewable energy applications.

⇥ Middle East & Africa: Emerging market fueled by rising interest in advanced materials, infrastructure development, and early-stage adoption in energy and construction sectors.

We Provide Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

FAQ

Q1: What is the current size of the Phospholipids Market?

A: The Phospholipids Market was valued at US$ 2.97 billion in 2023 and is forecasted to hit US$ 5.13 billion by 2031

Q2: How rapidly will the Market expanding?

A: The Phospholipids market is projected to grow at a CAGR of 7.03% between 2024 and 2031.

Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.